Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
EPA CPDat observed this chemical in 41617 composition records across product categories including Construction and building materials, Raw materials, Furniture and furnishings.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of TITANIUM DIOXIDE in our catalog (epa_cpdat).
Products
41,617
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 41617 composition records across product categories including Construction and building materials, Raw materials, Furniture and furnishings. EPA CPDat classifies this chemical for functional uses including Pigment, Dye, Brightener.
US
FDA
Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 3 mg
US
FDA
Cicaplast Baume B5+
La Roche Posay
Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 11 mg
US
FDA
Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 182 mg
US
FDA
Route: DENTAL; Dosage form: PASTE, DENTIFRICE; Potency: 0.4 %w/w
US
FDA
Route: INTRAUTERINE; Dosage form: SUPPOSITORY, EXTENDED RELEASE; Potency: 1 mg
US
FDA
Route: OPHTHALMIC; Dosage form: INSERT, EXTENDED RELEASE; Potency: 0.4 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 72 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED; Maximum daily exposure: 17 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 4.4 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 55 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 67 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 12 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 2 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 143 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 297 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 113 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 232 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 49 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 66 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 90 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 36 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 11 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 6 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 42 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: CAPSULE; Potency: NA
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: 2 mg
US
FDA
Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 80 mg
US
FDA
Route: TOPICAL; Dosage form: OINTMENT; Potency: 5 %w/w
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO, SUSPENSION; Potency: 3 %w/v
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 420 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: NA
US
FDA
FDA NDC lists this ingredient in 2721 active drug products and 2777 total products.
US
FDA
openFDA substance registry classifies this ingredient as chemical.